Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Choosing the right investment app can be daunting for beginners. We break down the best options to help you start investing confidently.
24,579 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Winter demand and a growing data-center footprint push grid strain. The Trump administration accelerates a coal reviv...
Amazon ends Walmart’s long hold on the Fortune 500 top spot, posting 2025 revenue of $716.9 billion to Walmart’s $713...
Eight trade groups push lower capital charges for mortgage servicing rights and advocate for tailored risk weights, a...
A new Fed letter argues that higher unauthorized immigration during the Biden era helped expand the labor pool in key...
U.S. equities drift as tariff uncertainty lingers, with the S&P 500 and SPY easing while investors await policy clari...
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
The Ethereum Foundation has begun staking ETH as part of a new treasury plan, coinciding with sales from Ethereum co-...
Solana vaults higher as Bitcoin steadies near $65,000, sparking a broad green across the crypto market. SOL gains led...
Zillow marks its 20th anniversary this month with a bold AI push to reinvent every step of the homebuying journey, fr...
Avantis U.S. Large Cap Value ETF (AVLV) has outpaced peers with a profitability-driven screen, posting a 24.5% gain o...
LINK jumped about 14% in 24 hours, reclaiming the $9 range on renewed interest in Canton Network integration and gro...